NasdaqCM - Delayed Quote USD

BioLife Solutions, Inc. (BLFS)

16.86 -0.33 (-1.92%)
At close: April 25 at 4:00 PM EDT
16.86 0.00 (0.00%)
After hours: April 25 at 4:20 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Roderick de Greef CEO & Chairman 1.63M -- 1960
Mr. Troy Wichterman Chief Financial Officer 485.2k 17.47k 1985
Ms. Karen Foster Chief Quality & Operations Officer 395.2k -- 1960
Dr. Aby J. Mathew Ph.D. Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer 448.2k 2.68M 1972
Mr. Todd Berard Chief Marketing Officer 286.49k -- 1969
Ms. Sarah Aebersold J.D. Chief Human Resources Officer -- -- 1977
Mr. Garrie Richardson B.Sc., M.B.A. Chief Revenue Officer -- -- 1973

BioLife Solutions, Inc.

3303 Monte Villa Parkway
Suite 310
Bothell, WA 98021
United States
425 402 1400 https://www.biolifesolutions.com
Sector: 
Healthcare
Full Time Employees: 
409

Description

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Corporate Governance

BioLife Solutions, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 6. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 3; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 08, 2024 - May 13, 2024
BioLife Solutions, Inc. Earnings Call

Related Tickers

AZTA Azenta, Inc.
51.50
-1.13%
 
ATRC AtriCure, Inc.
22.61
-1.91%
 
SRT3.DE Sartorius Aktiengesellschaft
282.10
-3.72%
 
ANIK Anika Therapeutics, Inc.
25.58
-1.24%
 
EMBC Embecta Corp.
10.40
-4.50%
 
DIM.PA Sartorius Stedim Biotech S.A.
203.40
-2.35%
 
NYXH Nyxoah S.A.
11.29
+5.51%
 
AKYA Akoya Biosciences, Inc.
3.8200
+0.26%
 
HAE Haemonetics Corporation
87.66
+1.67%
 
AKP.F Anika Therapeutics, Inc.
24.00
0.00%